Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)

Atrial Fibrillation Clinical Trial

Official title: Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)

Status Completed

Clinical Trial Summary

The purpose of this study is to find out if specialized programs in the AT500 and EnRhythm pacemakers will reduce the number of irregular heartbeat in the upper chamber of the heart and reduce symptoms (such as shortness of breath, dizziness, and others).

Clinical Trial Description

The purpose of the study was to confirm the AT500 intervention pacing effectiveness data previously seen in the ASPECT clinical trial and to gather additional data to understand the effectiveness of the intervention pacing features. Specifically, the goal of the trial is to demonstrate a reduction in frequency in symptomatic atrial tachycardia/atrial fibrillation recurrence with the intervention pacing features in patients with a pacing indication and a history of atrial tachyarrhythmias with atrial pacing leads located in the region of Bachmann's Bundle. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Related Conditions & MeSH terms

• Arrhythmia
• Atrial Fibrillation
• Bradycardia
• Tachycardia
• Tachycardia, Supraventricular

• NCT number: NCT00289289
• Study type: Interventional
• Source: Medtronic Cardiac Rhythm Disease Management
• Status: Completed
• Phase: N/A
• Start date: February 2004
• Completion date: July 2011